Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
153,881,229
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
33,363,531
-
Shares change
-
-646,532
-
Total reported value, excl. options
-
$63,033,295
-
Value change
-
-$410,004
-
Put/Call ratio
-
1,024%
-
Number of buys
-
35
-
Number of sells
-
-38
-
Price
-
$1.89
Significant Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q4 2023
91 filings reported holding ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 as of Q4 2023.
Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33,363,531 shares
of 153,881,229 outstanding shares and own 21.68% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (8,322,140 shares), RTW INVESTMENTS, LP (4,134,631 shares), MORGAN STANLEY (2,798,809 shares), COWEN AND COMPANY, LLC (2,715,278 shares), BlackRock Inc. (2,182,675 shares), Carlyle Group Inc. (2,115,385 shares), VANGUARD GROUP INC (1,685,075 shares), MILLENNIUM MANAGEMENT LLC (1,321,587 shares), TANG CAPITAL MANAGEMENT LLC (876,352 shares), and RENAISSANCE TECHNOLOGIES LLC (766,600 shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.